Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Nov 2021 – 20 Aug 2026, limited by DSP Nifty 50 Equal Weight ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | DSP Nifty 50 Equal Weight ETF | Nifty 50 |
|---|---|---|
| 08 Nov 2021 | ₹100.00 | ₹100.00 |
| 03 Apr 2022 | ₹97.75 | ₹97.80 |
| 26 Aug 2022 | ₹100.67 | ₹97.18 |
| 19 Jan 2023 | ₹103.72 | ₹100.22 |
| 13 Jun 2023 | ₹109.91 | ₹103.58 |
| 06 Nov 2023 | ₹118.17 | ₹107.43 |
| 30 Mar 2024 | ₹142.14 | ₹123.57 |
| 23 Aug 2024 | ₹161.82 | ₹137.38 |
| 15 Jan 2025 | ₹146.51 | ₹128.47 |
| 10 Jun 2025 | ₹160.69 | ₹138.94 |
| 02 Nov 2025 | ₹168.29 | ₹142.36 |
| 28 Mar 2026 | ₹154.58 | ₹126.29 |
| 20 Aug 2026 | ₹170.79 | ₹134.11 |
| Metric | DSP NAV ₹345.84 Very High risk ★★★★☆ | Category median Other ETFs · 248 funds |
|---|---|---|
| +4.93% | +3.65% | |
| +14.29% | +10.51% | |
| — | +9.28% | |
| — | +11.93% | |
| +11.85% | +10.38% | |
| +12.66% | — | |
| +17.05% | +14.30% | |
| — | +13.74% | |
| — | +12.83% | |
| Risk | ||
| 13.64% | 15.45% | |
| 0.57 | 0.28 | |
| 0.80 | 0.41 | |
| -17.99% | -20.59% | |
| Nifty 50 | — | |
| +5.75% | +0.80% | |
| 1.03 | 1.00 | |
| 115.0% | 102.1% | |
| 82.2% | 96.4% | |
| 0.31% | 0.32% | |
| ₹1,308Cr | ₹137.31Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Anil Ghelani | — | |
| 08 Nov 2021 | — | |
| 50 | — | |
| 22.3% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.